Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and…
The treatment combines Clearmind's MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc's Palmitoylethanolamide (PEA), the active ingredient of its proprietary CannAmide™ Tel Aviv, Israel / Vancouver,…